Search filters
Filters
Clear All

Phase

  • 54
  • 61
  • 2
  • 53
  • 1
  • 51
  • 11
  • 670
  • 926
  • 606
  • 5
  • 39
  • 886

Found 930 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

UPCC 29424 Safety and Efficacy of Dual Menin and FLT3 Inhibition in Patients with Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia Containing a Concurrent MLL-Rearrangement or NPM1 Mutation: A Phase 1 (Ph1) Study of SNDX-5613 + Gilteritinib

99 years and younger
All genders
Please refer to Protocol Section 2 (Objectives and Endpoints) Please refer to Protocol Section 2.1 (Primary Endpoints). Please refer to Protocol Section 2.2 (Secondary Endpoints)
Learn More

UPCC 41424 Preliminary Investigation of -Hydroxybutyrate Supplementation for Lymphoma Patients Receiving Anti-CD19 CAR T-Cells (BHB & CAR-T for Lymphomas)

99 years and younger
All genders
Please refer to Protocol Section 3 (Study Objectives and Endpoints). Please refer to Protocol Section 3 (Study Objectives and Endpoints). Please refer to Protocol Section 3 (Study Objectives and Endpoints).
Learn More

EA7222: A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas

99 years and younger
All genders
The EA7222 study is a randomized phase 3 trial of doxorubicin alone or in combination with pembrolizumab in patients with advanced UPS and related poorly differentiated sarcomas that cannot be removed by surgery (unresectable). The studys primary objective is to assess whether the combination therapy will improve PFS for this …
Learn More

UPCC 01523: A Phase III, Randomised, Open-label, Multicentre, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Durvalumab and Carboplatin Versus Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treat

99 years and younger
All genders
This is a Phase III, randomized, open-label, multicenter, global study to compare the efficacy and safety of Datopotamab Deruxtecan (Dato-DXd) in combination with durvalumab and carboplatin compared with pembrolizumab in combination with histology-specific platinum-based chemotherapy as first-line treatment of adults with stage IIIB, IIIC, or IV NSCLC without actionable genomic …
Learn More

UPCC 02424: A Phase 1b Multicenter, Open-label, Study of JNJ-90009530, an Autologous Anti-CD20 CAR-T Cell Therapy in Adult Participants with Relapsed or Refractory B-cell Non- Hodgkin Lymphoma

99 years and younger
All genders
The goal of this multicenter study is to test JNJ-90009530 in Relapsed or Refractory Non-Hodgkin Lymphoma Patients. The main questions the study aims to answer are: can a safe dose of JNJ-90009530 be determined that is safe and well tolerated by patients. will JNJ-90009530 help patients achieve a response and …
Learn More

Tufts R33 Prospective

99 years and younger
All genders
This prospective study is designed to find out whether a potential test can be used to identify neuropathic corneal pain patients
Learn More

UNI-RARE

99 years and younger
All genders
There are two components of this international, multicenter study: Registry A standardized genetic screening and a prospective, standardized, cross-sectional clinical data collection. Enrollment is open to all genes on the RD Rare Gene List Natural History Study A prospective, standardized, longitudinal Natural History Study Enrollment opens gene-by-gene, based on funding …
Learn More

The Rebalance Study

99 years and younger
All genders
To provide evidence for the safety and effectiveness of the May Health System in transvaginal ablation of ovarian tissue under transvaginal ultrasound guidance to restore ovulation in women with infertility due to polycystic ovary syndrome (PCOS) who have not responded to first-line ovulation induction treatment or are contraindicated for or …
Learn More

TA-8995-206

99 years and younger
All genders
Requesting a reliance agreement with an external IRB. The primary objective is to evaluate the efficacy of obicetrapib alone for 8 weeks as compared to obicetrapib in combination with Evolocumab for an additional 8 weeks after initial obicetrapib treatment on percent change of Lp(a) levels from Baseline in people with …
Learn More

Genimae DEV0123

99 years and younger
All genders
The purpose is to evaluate the number of Sjogren's dry eye patients also have decreased sensitivity on the surface of the eye. The study procedures that will be performed during the course of the study involves the following: Corneal Fluorescein staining, Ocular Pain Assessment Scale questionnaire, Corneal Sensitivity test, Schirmer …
Learn More
871 - 880 of 930